| Medical and Health Sciences | Lifetime | 205 | GB 23 | 99.99 |
| Biological Sciences | Lifetime | 697 | GB 67 | 99.92 |
| Medical and Health Sciences | 2021-2025 | 221 | GB 25 | 99.96 |
| Cardiology and Cardiovascular Medicine | Lifetime | 101 | GB 9 | 99.91 |
| Molecular Biology | Lifetime | 285 | GB 15 | 99.87 |
| Surgery | Lifetime | 648 | GB 49 | 99.39 |
| Immunology | Lifetime | 273 | GB 20 | 99.34 |
| Oncology | Lifetime | 539 | GB 43 | 99.00 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 525 | GB 60 | 98.38 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 867 | GB 80 | 97.65 |
| Rheumatology | Lifetime | 554 | GB 55 | 97.43 |
| Cancer Research | Lifetime | 844 | GB 54 | 93.69 |
| Nephrology | Lifetime | 752 | GB 42 | 88.97 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 99 | GB 8 | 99.53 |
| Epidemiology | 2021-2025 | 252 | GB 23 | 98.04 |
| Surgery | 2021-2025 | 673 | GB 45 | 94.11 |
| Infectious Diseases | 2021-2025 | 450 | GB 44 | 90.63 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 456 | GB 48 | 86.58 |
| Blood Pressure and Hypertension Studies | Lifetime | 6 | GB 1 | 99.94 |
| RNA regulation and disease | Lifetime | 3 | GB 1 | 99.92 |
| interferon and immune responses | Lifetime | 5 | GB 1 | 99.92 |
| Cardiovascular Health and Disease Prevention | Lifetime | 15 | GB 3 | 99.84 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 14 | GB 1 | 99.84 |
| RNA Research and Splicing | Lifetime | 76 | GB 6 | 99.57 |
| Hormonal Regulation and Hypertension | Lifetime | 52 | GB 6 | 99.59 |
| Sodium Intake and Health | Lifetime | 19 | GB 2 | 99.45 |
| RNA Interference and Gene Delivery | Lifetime | 197 | GB 8 | 99.34 |
| Heart Rate Variability and Autonomic Control | Lifetime | 146 | GB 10 | 99.25 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 290 | GB 31 | 99.30 |
| Hemodynamic Monitoring and Therapy | Lifetime | 159 | GB 16 | 98.71 |
| Renal and related cancers | Lifetime | 200 | GB 17 | 98.91 |
| Systemic Lupus Erythematosus Research | Lifetime | 392 | GB 46 | 98.76 |
| COVID-19 Clinical Research Studies | Lifetime | 640 | GB 63 | 97.70 |
| Immune Response and Inflammation | Lifetime | 539 | GB 34 | 98.65 |
| NF-κB Signaling Pathways | Lifetime | 162 | GB 9 | 98.18 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 979 | GB 85 | 98.50 |
| RNA and protein synthesis mechanisms | Lifetime | 857 | GB 58 | 98.34 |
| Angiogenesis and VEGF in Cancer | Lifetime | 320 | GB 22 | 97.95 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 815 | GB 134 | 98.19 |
| Clinical practice guidelines implementation | Lifetime | 210 | GB 43 | 97.44 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 247 | GB 20 | 97.54 |
| Cardiac Health and Mental Health | Lifetime | 867 | GB 76 | 95.05 |
| Galectins and Cancer Biology | Lifetime | 891 | GB 54 | 93.30 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 923 | GB 77 | 93.35 |
| Renin-Angiotensin System Studies | Lifetime | 676 | GB 45 | 94.48 |
| Heart rate and cardiovascular health | Lifetime | 112 | GB 10 | 92.32 |
| Complement system in diseases | Lifetime | 980 | GB 107 | 93.06 |
| Potassium and Related Disorders | Lifetime | 794 | GB 51 | 87.18 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 9 | GB 2 | 99.71 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 30 | GB 1 | 98.24 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 95 | GB 6 | 96.81 |
| COVID-19 Clinical Research Studies | 2021-2025 | 564 | GB 75 | 97.49 |
| Hormonal Regulation and Hypertension | 2021-2025 | 64 | GB 5 | 96.97 |
| Sodium Intake and Health | 2021-2025 | 25 | GB 3 | 96.95 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 310 | GB 20 | 95.02 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 74 | GB 7 | 94.23 |
| Emergency and Acute Care Studies | 2021-2025 | 274 | GB 26 | 93.29 |
| Cardiac Health and Mental Health | 2021-2025 | 592 | GB 45 | 86.37 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 657 | GB 35 | 83.67 |
| Clinical Reasoning and Diagnostic Skills | 2021-2025 | 426 | GB 30 | 74.99 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 306 | GB 45 | 68.69 |